Explore 130+ historical metrics & ratios
Compare equities side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance
Ramsay Health Care operates 72 private hospitals and day surgery facilities across Australia (primary market), France, UK, and Southeast Asia, with approximately 24,000 beds and 8.5 million patient admissions annually. The company generates revenue through elective surgeries, psychiatric care, and rehabilitation services, primarily serving privately insured patients and government-funded programs. Stock performance is driven by surgical volumes, occupancy rates, payor mix (private insurance vs. public funding), and regulatory changes in healthcare reimbursement across its geographic footprint.
Ramsay operates an asset-heavy model with significant fixed costs in facility leases, medical equipment, and staffing. Revenue is generated per admission with pricing determined by negotiated rates with private health insurers (Australia: Medibank, Bupa), government contracts (NHS in UK, Medicare in Australia), and self-pay patients. Pricing power varies by geography - strongest in Australia where private insurance penetration is 45% and weakest in UK where NHS contracts are fixed-price. Profitability depends on optimizing bed utilization (target 75-80% occupancy), surgical case mix (complex procedures generate higher margins), and controlling labor costs (60-65% of operating expenses). Scale advantages exist in procurement, shared services, and payor negotiations.
Surgical admission volumes and case mix - elective procedure deferrals during economic weakness or public health disruptions directly impact revenue
Private health insurance membership trends in Australia - 45% penetration rate drives ~55% of Australian revenue, sensitive to premium affordability and government rebate policies
Payor reimbursement rate negotiations - annual contract renewals with insurers and government programs (Medicare, NHS) determine revenue per admission
Labor cost inflation and nursing shortages - wage pressures in tight healthcare labor markets compress margins, particularly in Australia and UK
Regulatory changes to healthcare funding - Australian government private health insurance reforms, NHS budget allocations, French social security reimbursement rates
Shift toward value-based care and bundled payments - transition from fee-for-service to outcome-based reimbursement models reduces revenue predictability and shifts clinical risk to providers
Outpatient and ambulatory surgery center migration - technological advances enabling less invasive procedures threaten inpatient volumes, with 30-40% of surgeries potentially shifting to lower-cost outpatient settings over next decade
Government healthcare policy changes - Australian private health insurance reforms (means testing, rebate reductions), NHS funding pressures in UK, and French social security budget constraints create regulatory uncertainty
Aging infrastructure and capital intensity - hospital facilities require continuous $800M+ annual capex to maintain competitiveness, with average facility age creating obsolescence risk
Consolidation among private hospital operators - Healthscope acquisition by Brookfield creates larger competitor, while public hospital systems expanding private patient services increase competitive intensity
Physician alignment and employment models - shift toward hospital employment of physicians (versus independent practitioners) requires capital investment and changes referral dynamics
Payor vertical integration - health insurers developing owned provider networks (e.g., Bupa operating own facilities) threatens patient volumes and negotiating leverage
Elevated leverage at 2.42 Debt/Equity with $4.3B net debt limits financial flexibility - covenant headroom narrows if EBITDA declines, restricting M&A and dividend capacity
Current ratio of 0.90 indicates working capital pressure - reliance on operating cash flow to fund $800M annual capex creates liquidity risk if volumes decline
Currency exposure across AUD, EUR, GBP operations - approximately 35% of EBITDA from France and UK creates translation risk, though natural hedge exists through local currency debt
Defined benefit pension obligations in UK operations - underfunded status creates potential cash funding requirements if discount rates decline further
moderate - Elective surgeries exhibit cyclical sensitivity as patients defer non-urgent procedures during recessions when employment-linked private insurance coverage declines or out-of-pocket costs become burdensome. However, ~40% of revenue from government-funded programs (Medicare, NHS) and non-discretionary acute care provides downside protection. Australian market shows stronger GDP correlation due to high private insurance penetration, while UK operations are more stable due to NHS contracts. Psychiatric and rehabilitation services are relatively acyclical.
Rising interest rates negatively impact Ramsay through three channels: (1) higher debt servicing costs on $4.3B net debt (Debt/Equity 2.42), reducing net income; (2) valuation multiple compression as healthcare REITs and hospital operators trade at premium P/E ratios that contract when risk-free rates rise; (3) reduced M&A capacity as acquisition financing becomes more expensive, limiting growth optionality. Partially offset by ability to pass some costs through negotiated rate increases with payors, though typically with 12-18 month lag.
Moderate credit exposure through two mechanisms: (1) Private health insurers' financial health affects payment timeliness and willingness to approve high-cost procedures - insurer financial stress leads to stricter utilization management; (2) Patient bad debt increases during recessions as self-pay portions and deductibles become harder to collect, though this represents <5% of revenue. Government payor contracts (Medicare, NHS) have minimal credit risk. Overall credit exposure is manageable but not minimal given reliance on private insurance ecosystem.
value - Current 0.5x Price/Sales and 12.5x EV/EBITDA represent significant discount to historical 15-18x multiples, attracting value investors betting on margin recovery from depressed 0.1% net margin (down from historical 4-5%). High 12.7% FCF yield appeals to income-focused investors despite near-term earnings pressure. Defensive healthcare exposure with 77.3% gross margins attracts quality-focused value managers seeking cyclical recovery plays with structural growth tailwinds from aging demographics.
moderate - Healthcare services stocks typically exhibit beta of 0.7-0.9 to broader market given defensive characteristics, but Ramsay's geographic diversification and exposure to discretionary elective procedures creates moderate volatility. Stock sensitive to quarterly admission volume surprises, regulatory announcements affecting reimbursement, and currency swings. Recent -97% net income decline demonstrates earnings volatility from operational deleverage, though operating cash flow remains more stable at $1.5B.